HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keloid formation after syndactyly release in patients with associated macrodactyly: management with methotrexate therapy.

Abstract
We present a series of cases of keloid formation after release of syndactyly in the hands and feet of children with associated digital overgrowth. The use of methotrexate to suppress keloid formation after release of syndactyly and for control of recurrence after surgery for keloid is effective.
AuthorsS K Tolerton, M A Tonkin
JournalThe Journal of hand surgery, European volume (J Hand Surg Eur Vol) Vol. 36 Issue 6 Pg. 490-7 (Jul 2011) ISSN: 2043-6289 [Electronic] England
PMID21447529 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Dermatologic Agents
  • Folic Acid
  • Methotrexate
Topics
  • Adolescent
  • Child
  • Child, Preschool
  • Compression Bandages
  • Dermatologic Agents (therapeutic use)
  • Drug Therapy, Combination
  • Female
  • Fingers (abnormalities, surgery)
  • Folic Acid (therapeutic use)
  • Follow-Up Studies
  • Foot Deformities, Congenital (surgery)
  • Hand Deformities, Congenital (surgery)
  • Humans
  • Infant
  • Infant, Newborn
  • Keloid (drug therapy)
  • Male
  • Methotrexate (therapeutic use)
  • Postoperative Care (methods)
  • Postoperative Complications (drug therapy, surgery)
  • Reoperation
  • Secondary Prevention
  • Syndactyly (surgery)
  • Toes (abnormalities, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: